Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study

NCT06352554 is registered in ClinicalTrials.gov with SpeeDx Pty Ltd as lead sponsor.

NCT NCT06352554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06352554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study
Lead sponsor
SpeeDx Pty Ltd
Phase
Observational
Overall status
Unknown status
Start date
April 8, 2024
Completion date
January 30, 2025
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis, gonorrhea, resistance bacterial